Ticker Scorecard - ROIV Basics Company: Roivant Sciences Ltd. Common Shares IPO Date: January 1, 2021 Sector: Healthcare Industry: Biotech Market Cap: $7.62B Activated in VL: True Average Daily Range Avg Daily Range: $0.21 | 2.62% Avg Daily Range (30 D): $0.14 | 1.25% Avg Daily Range (90 D): $0.17 | 1.44% Institutional Daily Volume Avg Daily Volume: 2.41M Avg Daily Volume (30 D): 3.52M Avg Daily Volume (90 D): 3.67M Trade Size Avg Trade Size (Sh.): 147 Avg Trade Size (Sh.) (30 D): 140 Avg Trade Size (Sh.) (90 D): 150 Institutional Trades Total Inst.Trades: 2,261 Avg Inst. Trade: $3.27M Avg Inst. Trade (30 D): $3.2M Avg Inst. Trade (90 D): $3.81M Avg Inst. Trade Volume: .31M Avg Inst. Trades (Per Day): 3 Market Closing Trades Avg Closing Trade: $7.82M Avg Closing Trade (30 D): $6.32M Avg Closing Trade (90 D): $7.59M Avg Closing Volume: 735.55K     News Feb 20, 2025 @ 8:22 AM Will Moderna Stock Drop to $25? 1 Wall Street Anal... Source: Eric Volkman Oct 28, 2024 @ 1:25 PM Organon Completes Acquisition of Dermavant, includ... Source: Globe Newswire Sep 18, 2024 @ 7:20 PM Roivant Sciences Offloads Psoriasis Medicine Maker... Source: Benzinga Editor Sep 18, 2024 @ 11:30 AM Organon to Acquire Dermavant including its Innovat... Source: Globe Newswire Sep 10, 2024 @ 6:21 PM Roivant Sciences Unveils New 'Vant' Subsidiary For... Source: Vandana Singh Financials   TTM Q3 2025 Q2 2025 Basic EPS $.23 $-.31 Diluted EPS $.23 $-.31 Revenue $ $ 9.02M $ 4.48M Gross Profit $ $ $ Net Income / Loss $ $ 118.08M $ -279.92M Operating Income / Loss $ $ -274.38M $ -341.71M Cost of Revenue $ $ $ Net Cash Flow $ $ -26.13M $ -3666.73M PE Ratio